Lifeboat Foundation

(Medical Xpress)—A team of researchers at Sichuan University’s West China Hospital has announced plans to begin a clinical trial where cells modified using the CRISPR gene editing technique will be used on human beings for the very first time. They plan to edit genes in such a way as to turn off a gene that encodes for a protein that has been shown by prior research to slow an immune response and by so doing treat patients with lung cancer.

The CRISPR gene editing technique has been in the news a lot of late as scientists creep ever closer to using it as a means to treat diseases or to change the very nature of biological beings. China has been a leader in promoting such research on human beings—they were the first to use the technique to on human embryos.

This new effort is seen as far less controversial—a team in the U.S. is planning a similar study as soon as they can get regulators to greenlight their project. The Chinese team plans to retrieve T cells from patients that have incurable lung cancer and then edit the genes in those cells. More specifically, they will be looking to disable a gene that encodes for a protein called PD-1—prior research has shown that it acts as a brake on an immune response to help prevent attacks on healthy cells. Once the cells have been edited and inspected very carefully to make sure there were no editing errors they will be allowed to multiply and then all of the cells will be injected back into the same patient’s bloodstream. It is hoped that the edited cells will cause the immune system to mount a more aggressive attack on tumor cells, killing them and curing the patient.

Continue reading “Chinese team to pioneer first human CRISPR trial” »

The UK’s first double hand transplant operation has taken place at Leeds General Infirmary and the patient says his new hands look “tremendous”.

Chris King, from Doncaster, lost both his hands, apart from the thumbs, in an accident involving a metal pressing machine at work three years ago.

The 57-year-old received two new hands from a donor and says he already has some movement in them.

I do love biometrics for security; however, many know that we will not only leverage biometrics alone for certifying identification given how easy it is for folks to retrieve others DNA information, etc. from commercial DNA sites, etc.

In the world of security, there are many tools at the IT Staff’s disposal which can be used to fight Cybercrimes of all types and levels. Regarding Physical Access Entry, Smart Cards and FOB’s are available to help alleviate the probability of a Social Engineering attack. Regarding Logical Access Entry, Network Intrusion Devices, Firewalls, Routers, etc. are also all ready to be installed and used.

But, there is one problem with all of these tools above: To some degree or another, all of them can be hijacked, stolen, or even spoofed so that a real Cyber hacker can find their way into a corporation very quickly and easily. For instance, a Smart Card can be easily lost or stolen; or even malformed data packets can be sent to a router and tricking it that it is a legitimate employee trying to gain access.

Continue reading “BioCryptography and Biometric Penetration Testing” »

Like Botox; another bacteria found a new usage in healthcare.

Researchers at MIT and the University of California at San Diego (UCSD) have recruited some new soldiers in the fight against cancer—bacteria.

In a study appearing in the July 20 of Nature, the scientists programmed harmless strains of bacteria to deliver toxic payloads. When deployed together with a traditional cancer drug, the bacteria shrank aggressive liver tumors in mice much more effectively than either treatment alone.

Continue reading “Engineers program E. coli to destroy tumor cells” »

Wanted to share because I found this extremely interesting in what we’re discovery on implants and cells. I predict we are going to find out that in the next 7 to 10 years that we had some key things wrong as well as learned some new amazing things about cells especially with the synthetic cell & cell circuitry work that is happening for bio computing.

By Bikramjit Basu & his group Indian Institute of Science, Bangalore

For a variety of medical treatments these days, artificial, synthetic materials are inserted into the human body. Common examples include treatment for artery blockage and orthopaedic surgeries, like hip and knee replacements. Human bodies are not very receptive to foreign objects; most synthetic materials are rejected by the body. The choice of material that can be inserted, therefore, has to be very specific.

Continue reading “From the lab: Better biomaterials for medical implants” »

Building bio/ living computers in cells to combat diseases such as cancer, etc. as well as advance our evolution track towards sincularity.

Chemically hacking bacterial DNA allows for a whole new world of biological computation.

Grace LeClair had just finished eating dinner with friends when she got the phone call every parent dreads. The chaplain at the Medical College of Virginia was on the other end. “Your daughter has been in a serious accident. You should come to Richmond right away.” LeClair was in Virginia Beach at the time, a two-hour drive from 20-year-old Bess-Lyn, who was now lying in a coma in a Richmond hospital bed.

The friend who was with Bess-Lyn has since filled in the details of that day in March. The two women were bicycling down a steep hill, headed toward a busy intersection, when Bess-Lyn yelled that her brakes weren’t working and she couldn’t slow down. Her friend screamed for her to turn into an alley just before the intersection. But Bess-Lyn didn’t turn sharply enough and crashed, headfirst, into a concrete wall. She wasn’t wearing a helmet. By the time the ambulance reached the hospital, Bess-Lyn was officially counted among the 1.5 million Americans who will suffer a traumatic brain injury (TBI) this year.

Bess-Lyn’s mom was halfway to Richmond when she received a second call, this time from a doctor. “He was telling me that she had a very serious injury, that she had to have surgery to save her life and that if I would give permission, they would use this experimental, not-approved-by-the-FDA drug,” Grace LeClair recalls. “He said that it would increase the oxygen supply to her brain. To me that only made sense, so I said yes.”

Continue reading “Better Than Blood?” »

NASA’s Space Technology Mission Directorate (STMD) worked with two private firms to develop advanced structures for high power solar arrays that are stronger, lighter, and package more compactly for launch. This technology investment furthers the agency’s deep space exploration goals and aids the commercial communications satellite industry, the provider of direct-to-home television, satellite radio, broadband internet and a multitude of other services.

The Roll Out Solar Array (ROSA) is one of the options eyed by NASA that could power an advanced solar electric propulsion spacecraft that makes possible such endeavors as the agency’s Asteroid Redirect Mission—plucking a multi-ton boulder from an asteroid’s surface, and then maneuvering that object into a stable orbit around the moon for human inspection and sampling.

Tapping into ROSA technology allows the conversion of sunlight into electrical power that drives the ion thrusters of a solar electric propulsion spacecraft. ROSA is expected to enable a number of space initiatives and is a cost-saving plus to transport cargo over long distances beyond the Earth.

Continue reading “Roll Out Solar Array Technology: Benefits for NASA, Commercial Sector” »

Mayo Clinic researchers have developed the first liquid biopsies from blood tests and DNA sequencing that can detect ovarian cancer long before a tumor reappears.

The advance, reported by the Mayo Clinic Center for Individualized Medicine, provides a promising new way to monitor and treat recurrences of ovarian cancer — a hard-to-detect disease that claims many lives.

Lead researcher Dr. George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, said the development could lead to earlier intervention and more effective, individualized treatment for the often-fatal condition.

Continue reading “Liquid Biopsies Developed for Ovarian Cancer: Mayo Clinic” »